A rapid, sensitive electron-capture gas chromatographic procedure for analysis of metabolites of N-methyl,N-propargylphenylethylamine, a potential neuroprotective agent

Journal of Pharmacological and Toxicological Methods

Volumn 52, Issue 3, 2005, Pages 373-378

  Rittenbach, Kay ^a   Sloley, B Duff ^b,c   Ling, Lei ^b   Coutts, Ronald T ^a   Shan, Jackie ^b   Baker, Glen B ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

^b CV Technologies Inc   (Canada)

^c Novokin Biotech Inc   (Canada)

Author keywords

phenylethylamine; ( ) deprenyl; Electron capture gas chromatography method; N methyl,N propargylphenylethylamine; N methylphenylethylamine; N propargylphenylethylamine; Neuroprotective; Pentafluorobenzenesulfonyl chloride

Indexed keywords

CHLORIDE; DRUG METABOLITE; ETHYLAMINE; N METHYL N PROPARGYLPHENYLETHYLAMINE; N METHYLPHENETHYLAMINE; N PROPARGYLPHENYLETHYLAMINE; NEUROPROTECTIVE AGENT; PENTAFLUOROBENZENESULFONYL CHLORIDE; PHENETHYLAMINE; UNCLASSIFIED DRUG;

ARTICLE; DERIVATIZATION; DRUG METABOLISM; ELECTRON CAPTURE DETECTION; GAS CHROMATOGRAPHY; HUMAN; HUMAN CELL; LIVER MICROSOME METABOLISM; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY;

GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; METHAMPHETAMINE; MICROSOMES, LIVER; NEUROPROTECTIVE AGENTS; PHENETHYLAMINES; SELEGILINE; SULFONES; TIME FACTORS;

EID: 27344456293     PISSN: 10568719     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vascn.2005.07.001     Document Type: Article

References (26)

1. O.B. Am, T. Amit, and M.B.H. Youdim Contrasting neuroprotective and neurotoxic actions of respective metabolites of anti-Parkinson drugs rasagiline and selegiline Neuroscience Letters 355 2004 169 172
2. S.J. Asghar, G.B. Baker, G.A. Rauw, and P.H. Silverstone A rapid method of determining amphetamine in plasma samples using pentafluorobenzenesulfonyl chloride and electron-capture gas chromatography Journal of Pharmacological and Toxicological Methods 46 2001 111 115
3. G.B. Baker, M. Koilpillai, A.J. Nazarali, T.S. Rao, and R.T. Coutts Gas chromatography of antidepressants and their metabolites as pentafluorobenzoyl and pentafluorobenzenesulfonyl derivatives Proceedings of the Western Pharmacology Society 29 1986 291 294
4. G.B. Baker, T.S. Rao, and R.T. Coutts Electron-capture gas chromatographic analysis of beta-phenylethylamine in tissues and body fluids using pentafluorobenzenesulfonyl chloride for derivatization Journal of Chromatography Biomedical Applications 381 1986 211 217
5. Birks, J. & Flicker, L. (2003). Selegiline for Alzheimer's disease. Cochrane Database System Review, CD000442.
6. V.W. DeLaGarza Pharmacologic treatment of Alzheimer's disease: An update American Family Physician 68 2003 1365 1372
7. M. Ebadi, S. Sharma, S. Shavali, and H. El Refaey Neuroprotective actions of selegiline Journal of Neuroscience Research 67 2002 285 289
8. E.H. Heinonen, and V. Myllyla Safety of selegiline (deprenyl) in the treatment of Parkinson's disease Drug Safety 19 1998 11 22
9. E. Kwan, G.B. Baker, A. Shuaib, L. Ling, and K.G. Todd N-Methyl,N-propargyl-2-phenylethylamine (MPPE), an analog of deprenyl, increases neuronal cell survival in thiamin deficiency encephalopathy Drug Development Research 51 2000 244 252
10. Z.Q. Liu, Z.R. Tan, D. Wang, S.L. Huang, L.S. Wang, and H.H. Zhou Simultaneous determination of fluoxetine and its metabolite p- trifluoromethylphenol in human liver microsomes using a gas chromatographic- electron-capture detection procedure Journal of Chromatography B Analytical Technologies in the Biomedical Life Sciences 769 2002 305 311
11. K. Magyar, and B. Szende (-)-Deprenyl, a selective MAO-B inhibitor, with apoptotic and anti-apoptotic properties Neurotoxicology 25 2004 233 242
12. S. Mandel, E. Grunblatt, P. Riederer, M. Gerlach, Y. Levites, and M.B. Youdim Neuroprotective strategies in Parkinson's disease: An update on progress CNS Drugs 17 2003 729 762
13. P.R. Paetsch, G.B. Baker, L.E. Caffaro, A.J. Greenshaw, G.A. Rauw, and R.T. Coutts Electron-capture gas chromatographic procedure for simultaneous determination of amphetamine and N-methylamphetamine Journal of Chromatography Biomedical Applications 573 1992 313 317
14. I.A. Paterson, D. Zhang, R.C. Warrington, and A.A. Boulton R-deprenyl and R-2-heptyl-N-methylpropargylamine prevent apoptosis in cerebellar granule neurons induced by cytosine arabinoside but not low extracellular potassium Journal of Neurochemistry 70 1998 515 523
15. P. Riederer, and L. Lachenmayer Selegiline's neuroprotective capacity revisited Journal of Neural Transmission 110 2003 1273 1278
16. I. Semkova, P. Wolz, M. Schilling, and J. Krieglstein Selegiline enhances NGF synthesis and protects central nervous system neurons from excitotoxic and ischemic damage European Journal of Pharmacology 315 1996 19 30
17. A. Sentissi, M. Joppich, K. O'Connell, A. Nazareth, and R.W. Giese Pentafluorobenzenesulfonyl chloride: A new electrophoric derivatizing reagent with application to tyrosyl peptide determination by gas chromatography with electron capture detection Analytical Chemistry 56 1984 2512 2517
18. H.S. Shin Metabolism of selegiline in humans. Identification, excretion, and stereochemistry of urine metabolites Drug Metabolism and Disposition 25 1997 657 662
19. B.N. Sowa, K.G. Todd, V.A.M.I. Tanay, A. Holt, and G.B. Baker Amine oxidase inhibitors and development of neuroprotective drugs Current Neuropharmacology 2 2004 153 168
20. F. Stocchi, and C.W. Olanow Neuroprotection in Parkinson's disease: Clinical trials Annuals of Neurology 53 Suppl 3 2003 S87 S97 Discussion 2003 S97 S99
21. P. Taavitsainen, M. Anttila, L. Nyman, H. Karnani, J.S. Salonen, and O. Pelkonen Selegiline metabolism and cytochrome P450 enzymes: In vitro study in human liver microsomes Pharmacology and Toxicology 86 2000 215 221
22. T. Tabi, K. Magyar, and E. Szoko Chiral characterization of deprenyl-N-oxide and other deprenyl metabolites by capillary electrophoresis using a dual cyclodextrin system in rat urine Electrophoresis 24 2003 2665 2673
23. W.G. Tatton Selegiline can mediate neuronal rescue rather than neuronal protection Movement Disorders 8 Suppl 1 1993 S20 S30
24. W.G. Tatton, and R.M. Chalmers-Redman Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration Neurology 47 1996 S171 S183
25. W.G. Tatton, R.M. Chalmers-Redman, M. Elstner, W. Leesch, F.B. Jagodzinski, and D.P. Stupak Glyceraldehyde-3-phosphate dehydrogenase in neurodegeneration and apoptosis signaling Journal of Neural Transmission 2000 77 100
26. L.J. Urichuk, L.J. Aspeslet, A. Holt, P.H. Silverstone, R.T. Coutts, and G.B. Baker Determination of p-trifluoromethylphenol, a metabolite of fluoxetine, in tissues and body fluids using an electron-capture gas chromatographic procedure Journal of Chromatography B Biomedical Sciences and Applications 698 1997 103 109